Position in SCLX
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$600
+$88 QoQ
Shares Held
77
-37.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 72 holders
Holding Since
Mar 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Avion Wealth holds $2,127,631 across 13 Drug Manufacturers - General names. SCLX ranks #13 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
772 | $925,960 | |
| 2 | JNJ |
Johnson & Johnson
|
1,663 | $422,352 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,071 | $266,123 | |
| 4 | AMGN |
Amgen Inc
|
623 | $225,600 | |
| 5 | ABBV |
AbbVie Inc.
|
504 | $126,826 | |
| 6 | PFE |
Pfizer Inc
|
1,719 | $41,393 | |
| 7 | AZN |
Astrazeneca PLC
|
197 | $37,355 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
203 | $25,647 |
All Filings in SCLX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $600 | 77 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $512 | 77 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $939 | 77 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $1 | 77 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $453 | 77 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $497 | 2,000 | Shares | Sole | 2025-05-09 | |
| 2024-03-31 | $1 | 365 | Shares | Sole | 2024-05-03 | |
| No filing history on record for this holder in this stock. | ||||||